JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CTR
5001
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
| $5K | ﹤0.01% |
399
| – | – |
2015 Q3
19 quarters
|
|
|
KLR
5002
DELISTED
Kaleyra, Inc.
KLR
| $5K | ﹤0.01% |
+357
| New | +$8K |
2020 Q2
0 quarters
|
|
|
SRLP
5003
DELISTED
SPRAGUE RESOURCES LP
SRLP
| $5K | ﹤0.01% |
300
| – | – |
2020 Q1
1 quarter
|
|
|
SFUN
5004
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $5K | ﹤0.01% |
483
-17,414
| -97% | -$206K |
2015 Q3
19 quarters
|
|
|
JSD
5005
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
| $5K | ﹤0.01% |
424
| – | – |
2014 Q4
22 quarters
|
|
|
CELP
5006
DELISTED
Cypress Environmental Partners, L.P.
CELP
| $5K | ﹤0.01% |
1,250
-3,250
| -72% | -$15.4K |
2020 Q1
1 quarter
|
|
5007
Ascent Industries
ACNT
$124M
| $4K | ﹤0.01% |
538
-5,315
| -91% | -$46.2K |
2018 Q2
8 quarters
|
|
|
BBU
5008
DELISTED
Brookfield Business Partners
BBU
| $4K | ﹤0.01% |
179
| – | – |
2016 Q2
16 quarters
|
|
5009
Capital Southwest
CSWC
$1.5B
| $4K | ﹤0.01% |
307
-5,456
| -95% | -$70.5K |
2016 Q1
17 quarters
|
|
5010
Flotek Industries
FTK
$1.12B
| $4K | ﹤0.01% |
499
-56,379
| -99% | -$323K |
2015 Q4
18 quarters
|
|
|
NBP
5011
NovaBridge Biosciences American Depositary Shares
NBP
$156M
| $4K | ﹤0.01% |
+147
| New | +$3.04K |
2020 Q2
0 quarters
|
|
5012
iShares S&P India Nifty 50 Index Fund
INDY
$495M
| $4K | ﹤0.01% |
114
| – | – |
2017 Q2
12 quarters
|
|
5013
Lipocine
LPCN
$16.9M
| $4K | ﹤0.01% |
176
| – | – |
2019 Q1
5 quarters
|
|
5014
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$95.5M
| $4K | ﹤0.01% |
78
| – | – |
2019 Q3
3 quarters
|
|
|
NCSM
5015
DELISTED
NCS Multistage Holdings
NCSM
| $4K | ﹤0.01% |
376
-652
| -63% | -$7.5K |
2017 Q3
11 quarters
|
|
5016
OFS Capital
OFS
$46.6M
| $4K | ﹤0.01% |
887
-27,588
| -97% | -$128K |
2017 Q2
12 quarters
|
|
|
PR
5017
Permian Resources
PR
$18.5B
| $4K | ﹤0.01% |
5,000
| – | – |
2017 Q2
12 quarters
|
|
|
SA
5018
Seabridge Gold
SA
$2.91B
| $4K | ﹤0.01% |
206
| – | – |
2018 Q3
7 quarters
|
|
5019
Grupo SIMEC
SIM
| $4K | ﹤0.01% |
670
| – | – |
2015 Q4
18 quarters
|
|
5020
iShares Russell 2500 ETF
SMMD
$4.08B
| $4K | ﹤0.01% |
100
| – | – |
2019 Q2
4 quarters
|
|
5021
ProShares UltraPro Short 20+ Year Treasury
TTT
$28.8M
| $4K | ﹤0.01% |
125
-194
| -61% | -$5.72K |
2018 Q4
6 quarters
|
|
|
XNET
5022
Xunlei
XNET
$300M
| $4K | ﹤0.01% |
1,268
+648
| +105% | +$2.22K |
2020 Q1
1 quarter
|
|
5023
cbdMD
YCBD
$5.11M
| $4K | ﹤0.01% |
6
-159
| -96% | -$71.3K |
2019 Q2
4 quarters
|
|
|
WWE
5024
PUT
DELISTED
World Wrestling Entertainment
WWE
| $4K | ﹤0.01% |
100
| – | – |
2020 Q1
1 quarter
|
|
|
TESS
5025
DELISTED
Tessco Technologies Inc
TESS
| $4K | ﹤0.01% |
664
-6,540
| -91% | -$34.7K |
2019 Q2
4 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.